Impact of statin use on short- and long-term outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database
Frontiers in Pharmacology · 19.03.2025 · 16
DOI: 10.3389/fphar.2025.1520107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 19.03.2025. Verfasst von Yuan Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background
Sepsis-induced myocardial injury (SIMI) is a critical complication of sepsis, marked by high mortality rates, and lacks effective treatments. The impact of statin therapy on mortality in SIMI patients remains unclear. This study aims to explore the association between statin use and mortality in SIMI patients, focusing on both short-term and long-term outcomes.
Methods
A retrospective cohort study was conducted by extracting SIMI patient information from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. Patients were categorized into statin and non-statin groups. A 1:1 nearest propensity-score matching (PSM) was used to balance baseline characteristics. Survival outcomes were assessed using Kaplan-Meier analysis and robust Cox proportional hazards models to understand the effects of statin use, type and dosage on mortality at 28 days, 90 days, and 1 year. E-Value analysis was used for unmeasured confounding.
Results
A total of 2,246 patients meeting SIMI criteria were enrolled in the final cohort, with 17.9% receiving statins during their ICU stay. Statin use was associated with significantly lower mortality at all time points, as shown by Kaplan-Meier analysis. In multivariable robust Cox regression models, statin therapy correlated with a 32% reduction in 28-day mortality (HR = 0.68, 95% CI: 0.49–0.94), a 29% reduction at 90 days (HR = 0.71, 95% CI: 0.54–0.93), and a 28% reduction at 1 year (HR = 0.72, 95% CI: 0.58–0.90), maintaining significance after adjustment for confounders. Simvastatin was particularly effective, and low-dose statins were linked to reduced mortality risk. Subgroup analyses suggested consistent statin benefits. E-Value analysis suggested robustness to unmeasured confounding.
Conclusion
Our study demonstrates that statin use is significantly associated with reduced mortality in SIMI patients across 28 days, 90 days, and 1 year. Simvastatin provides substantial benefits, with low-dose statins providing greater advantages compared to high-dose formulations.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Zitieren
APA
Liu, Y., Chen, J., Yuan, Y., Niu, P., Wu, M., Shang, B., Lu, W., Zou, X., & Yao, G. (2025). Impact of statin use on short- and long-term outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1520107
Vancouver
Liu Y, Chen J, Yuan Y, Niu P, Wu M, Shang B, et al. Impact of statin use on short- and long-term outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1520107
BibTeX
@article{Liu2025,
author = {Liu, Yuan and Chen, Jijiang and Yuan, Yehao and Niu, Pingping and Wu, Mengyi and Shang, Baoling and Lu, Weihui and Zou, Xu and Yao, Gengzhen},
title = {Impact of statin use on short- and long-term outcomes in patients with sepsis-induced myocardial injury: insights from the MIMIC-IV database},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1520107}
}
EUVIMED